Amgen And MBC BioLabs Announce Winners Of The Amgen Golden Ticket

Two Biotherapeutic Companies Receive Lab Space and Other Benefits to Further Advance Innovative Science at Bay Area Life Sciences Incubator SAN FRANCISCO, June 25, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and MBC BioLabs (formerly QB3@953) today announced that Regencor and Nitrome Biosciences have each been awarded an Amgen Golden Ticket to MBC BioLabs. The companies receive priority admission or renewal for one year of lab bench space and access to core facilities at the MBC BioLabs life sciences incubator, as well as connections to Amgen's scientific and business leaders to help advance their scientific programs. Amgen has been sponsoring MBC BioLabs since 2016 to assist high-potentia...
Source: Amgen News Release - Category: Pharmaceuticals Tags: Uncategorized Source Type: news